Chelsea’s highly‑rated winger Mykhailo Mudryk has taken his case to the Court of Arbitration for Sport (CAS) after the English Football Association handed him a four‑year ban for an alleged doping violation. The appeal was formally lodged on 25 February, according to a CAS statement confirming receipt of the paperwork.
Neither the FA, the London club nor Mudryk’s legal representatives have offered any public comment on the matter so far. Mudryk arrived at Chelsea in January 2023 from Ukrainian side Shakhtar Donetsk for a reported fee of around £88 million, signing a contract that still has five years remaining. The suspension stems from a positive test for the prohibited stimulant meldonium, a substance that was added to the World Anti‑Doping Agency’s banned list several years ago. Mudryk maintains that the sample was contaminated while he was representing Ukraine on international duty in October 2024, and that he never intentionally ingested any banned material.
The Football Association initially placed Mudryk on provisional suspension in December 2024 after the laboratory result was reported. In a brief statement released at the time, the 23‑year‑old expressed shock at the outcome, insisting that he "had not done anything wrong" and that he was confident the test result was erroneous. Chelsea launched its own internal investigation shortly after the FA’s action, emphasizing that the player had repeatedly affirmed he had never knowingly used a prohibited drug. Since his suspension, Mudryk has been unable to feature for Chelsea, missing almost a season and a half of competitive football.
The last time he appeared for the club was on 28 November 2024, when he scored in a 2‑0 Conference League victory over German side Heidenheim. Since then, he has kept himself in shape by training with personal coaches away from the club’s Cobham facilities, awaiting the outcome of the legal process. The appeal to CAS is the next step in a long and uncertain journey.
As Sky Sports’ chief correspondent Kaveh Solhekol explained, the only confirmation that Mudryk is challenging the ban comes from the CAS filing itself; the FA has remained silent, citing the confidentiality of the proceedings, and Chelsea and the player’s lawyers have also refrained from speaking publicly. Solhekol noted that Mudryk’s case is particularly noteworthy because the alleged violation occurred during an international match for Ukraine, not while he was on club duty. If the Court upholds the FA’s decision, Mudryk’s four‑year ban would effectively keep him out of professional football until the end of 2028, a severe penalty for a player who was once considered one of the most promising talents in Europe.
Such an outcome would not only derail his personal career but also represent a significant financial loss for Chelsea, who invested a record sum in his transfer and have not been able to utilise his services for more than 18 months. The broader context of the case touches on the ongoing debate surrounding meldonium, a drug originally developed to treat heart conditions but later banned for its performance‑enhancing potential.
Several athletes in recent years have claimed inadvertent ingestion or contamination, leading to a series of high‑profile disputes in the sporting world. Mudryk’s legal team is expected to argue that the testing protocol was flawed or that the sample was compromised during the hectic travel and training schedule associated with international fixtures. While the appeal process can be lengthy, both parties are bound by strict procedural rules that aim to ensure fairness.
CAS will review the evidence presented by the FA, including laboratory reports and chain‑of‑custody documentation, as well as Mudryk’s defense, which may include expert testimony on the likelihood of contamination and the timing of the sample collection. The tribunal’s decision will set a precedent for how similar cases are handled in the future, particularly those involving young players who split their time between club and country.
In the meantime, Chelsea has indicated that it will respect the legal process and allow the matter to run its course, without interfering with the arbitration. The club’s management has also hinted that they remain hopeful for a positive resolution, given the player’s potential value both on and off the pitch. Fans and pundits alike are watching closely, aware that the outcome could reshape the narrative around doping controls in football and the responsibilities of national associations in safeguarding athletes from inadvertent violations.
Until a definitive ruling is issued, Mudryk remains on provisional suspension, training independently, and hoping that the appeal will overturn the ban that has kept him away from the sport he loves for nearly two years.